Has MindRank reduced R&D costs by 60% with its AI-assisted drug?
Hangzhou-based biotech start-up MindRank has reached Phase 3 clinical trials for its weight-loss drug, marking a first for China’s AI-assisted Category 1 new drugs. The...
This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info